Ubs Group Ag Entera Bio Ltd. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Entera Bio Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 167,623 shares of ENTX stock, worth $336,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
167,623
Previous 149,869
11.85%
Holding current value
$336,922
Previous $250,000
23.2%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ENTX
# of Institutions
17Shares Held
5.31MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$7.8 Million4.83% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY672KShares$1.35 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT402KShares$807,0510.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny57.6KShares$115,7750.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA28.9KShares$58,0000.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $57.9M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...